Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Working Capital Changes (2016 - 2025)

Cytosorbents' Other Working Capital Changes history spans 15 years, with the latest figure at -$802000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$802000.0 for Q4 2025, down 80300.0% from a year ago — trailing twelve months through Dec 2025 was -$150931.0 (down 107.18% YoY), and the annual figure for FY2025 was $373775.0, down 53.11%.
  • Other Working Capital Changes for Q4 2025 was -$802000.0 at Cytosorbents, down from $908000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q4 2022 to a low of -$802000.0 in Q4 2025.
  • The 5-year median for Other Working Capital Changes is $127032.5 (2022), against an average of $232537.2.
  • The sharpest move saw Other Working Capital Changes skyrocketed 166571.72% in 2022, then crashed 80300.0% in 2025.
  • Year by year, Other Working Capital Changes stood at -$916.0 in 2021, then skyrocketed by 166571.72% to $1.5 million in 2022, then fell by 10.12% to $1.4 million in 2023, then tumbled by 99.93% to $1000.0 in 2024, then crashed by 80300.0% to -$802000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$802000.0, $908000.0, and $187177.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.